Mangoceuticals, Inc. (MGRX) vs ENDRA Life Sciences Inc. (NDRA)
A side-by-side comparison of Mangoceuticals, Inc. and ENDRA Life Sciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MGRX
Mangoceuticals, Inc.
$0.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NDRA
ENDRA Life Sciences Inc.
$6.04HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MGRX vs NDRA
growth of $100 · dividends reinvested · last 4yMGRX -99.3% (-71.1%/yr)NDRA -99.9% (-82.1%/yr)MGRX compounded faster over this window
Log scale — wide-divergence pair
MGRX NDRA
MGRX vs NDRA: by the numbers
- •NDRA is the larger company ($8M vs $8M market cap).
- •Both run net losses; NDRA's is the smaller (0.00% vs -4791.48% net margin).
Metrics side by side
Valuation
| Metric | MGRX | NDRA |
|---|---|---|
| P/S ratio | 24.22 | N/A |
| P/B ratio | 0.61 | 1.22 |
Profitability
| Metric | MGRX | NDRA |
|---|---|---|
| Gross margin | 54.43% | 0.00% |
| Operating margin | -4200.46% | 0.00% |
| Net margin | -4791.48% | 0.00% |
| ROE | -120.58% | -93.77% |
| ROIC | -102.91% | -92.93% |
Growth (annualized)
| Metric | MGRX | NDRA |
|---|---|---|
| Total return CAGR (5Y) | N/A | -83.91% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.